market is driven by the rising prevalence of diabetes, the growing demand for self-monitoring of blood glucose levels, and advancements in technology.

Medical technology manufacturer plans to divest diabetes products business / Focus on injection systems © 2001-2024 Plasteurope.com | Imprint | Privacy | Cookie settings ...

Overview: Vivendi SE is a global entertainment, media, and communication company with operations across Europe, the Americas, Asia/Oceania, and Africa, and has a market cap of approximately €8.90 ...

Switzerland is scrambling to keep a lid on immigration from its top trade partner, the European Union, as a jobs boom powered ...

Switzerland is scrambling to keep a lid on immigration from its top trade partner, the European Union, as a jobs boom powered ...

Advancements in medical technology and increasing awareness about diabetes and blood testing drive innovation and adoption in the lancet industry.